Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barnes-Seeman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|February 4, 2014
Fluorinated compounds in medicinal chemistry: recent applications, synthetic advances and matched-pair analysesDavid Barnes-Seeman, Jeremy Beck, Clayton Springer
Angewandte Chemie (International Ed. in English)|June 5, 2003
Expanding the functional group compatibility of small-molecule microarrays: discovery of novel calmodulin ligandsDavid Barnes-Seeman, Seung Bum Park, Angela N Koehler, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolically Stable tert-Butyl ReplacementDavid Barnes-Seeman, Monish Jain, Leslie Bell, et al.
International Journal of Toxicology|June 9, 2017
Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in ObesityAlan P Brown, Chandrassegar Saravanan, Patrick Devine, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2014
Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitorsDavid Barnes-Seeman, Carri Boiselle, Christina Capacci-Daniel, et al.
Chemistry & Biology|May 25, 2006
A robust small-molecule microarray platform for screening cell lysatesJames E Bradner, Olivia M McPherson, Ralph Mazitschek, et al.
Cell Chemical Biology|January 10, 2023
Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligandsJeffrey T Bagdanoff, Thomas M Smith, Martin Allan, et al.
Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family ApproachEdwige Lorthiois, James Roache, David Barnes-Seeman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|February 4, 2014
Fluorinated compounds in medicinal chemistry: recent applications, synthetic advances and matched-pair analysesDavid Barnes-Seeman, Jeremy Beck, Clayton Springer
Angewandte Chemie (International Ed. in English)|June 5, 2003
Expanding the functional group compatibility of small-molecule microarrays: discovery of novel calmodulin ligandsDavid Barnes-Seeman, Seung Bum Park, Angela N Koehler, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolically Stable tert-Butyl ReplacementDavid Barnes-Seeman, Monish Jain, Leslie Bell, et al.
International Journal of Toxicology|June 9, 2017
Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in ObesityAlan P Brown, Chandrassegar Saravanan, Patrick Devine, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2014
Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitorsDavid Barnes-Seeman, Carri Boiselle, Christina Capacci-Daniel, et al.
Chemistry & Biology|May 25, 2006
A robust small-molecule microarray platform for screening cell lysatesJames E Bradner, Olivia M McPherson, Ralph Mazitschek, et al.
Cell Chemical Biology|January 10, 2023
Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligandsJeffrey T Bagdanoff, Thomas M Smith, Martin Allan, et al.
Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family ApproachEdwige Lorthiois, James Roache, David Barnes-Seeman, et al.
Pageof 1